Membership Area
Forgot password?
To register place your 1st order
All our papers are  WRITTEN FROM SCRATCH
All our papers are
We do not compromise the quality of the papers delivered. At, you can trust our refund policy. If you prove that a low quality paper has been delivered, you get your money back!
100% Quality guarantee
Do you want some real proof that we can cope with your essay? The customers' reviews about our services are the most substantial evidence of our writing quality. Why don't you have a look at our testimonials and see why people come back to our website every semester?
100% Quality guarantee
All you need to do is choose the type of your future paper, set the deadline, provide us with all the necessary details regarding your paper, wait a bit, and download the final product created by our professionals.
3 main reasons why you should
  • Affordable prices.
  • Quality papers.
  • On time delivery.
100% Quality guarantee
DISCOUNTS offers 2 kinds of discount programs to customers. The first type is for the first-time customers. It allows them to save up to 15% on the first order. The second one is a fidelity program for our returning clients. It is possible to get lifetime discounts of 5%, 10%, and 15% off the original price.
100% Quality guarantee
An attractive option, which allows you to always view your demo account, is another thing which proves professionalism of our writing service. It will help you evaluate our company's performance during the working process.
← Factors in the Macro EnvironmentObstacles for Studying Abroad →

Danish Insulin Producer Novo Nordisk

Buy Custom Danish Insulin Producer Novo Nordisk Essay

Danish insulin producer Novo Nordisk A/S is one of the leading transnational corporations in the sector. Thus, this paper provides the research of Novo Nordisk’s marketing mix. It includes exploring its products, price, distribution channels, and promotion system.

Product and Price

Novo Nordisk has two product lines: diabetes care and biopharmaceuticals. Novo Nordisk’s modern insulin, also called insulin analogues (Levemir®, Novo Rapid®, Novo Mix®), is the newest kind of insulin in the market (Novo Nordisk, 2012). Their action is more predictable and safe for patients. Human insulin (Insulatard®, Actrapid®, Mixtard® 30) is made by recombinant DNA technology. Comparatively to modern insulins, it is less similar to human physiology (Shah, 2009). Glucagon-Like Peptide-1 (Victoza®) and oral antidiabetic agents (NovoNorm®, PrandiMet®) are used for diabetes type 1.

Diabetes devices are represented with prefilled insulins delivery systems (FlexTouch®, FlexPen®, Innolet®), durable insulins delivery systems (NovoPen®), needles delivery systems (NovoFine®, NovoTwist®), glucagon (GlucaGen®). Changes in diabetes devices are increasingly dynamic nowadays; thus, it is a key sphere for Novo Nordisk (Novo Nordisk, 2012).

There are three groups of biopharmaceuticals produced by Novo Nordisk. They include haemostasis (NovoSeven®), human growth hormone with DNA origin (Nodritropin®), prefilled multidose delivery systems (Nodritropin®, FlexPro®, NordiFlex®, NordiPen®, NordiPenMate®), automatic needle insertion (NordiFlex Penmate®, NordiLet®), and hormone replacement therapy (Activelle®, Estrofem®, Novofem®, Vagifem®) (Novo Nordisk, 2012).

Novo Nordisk uses a differential pricing policy based on preferences. The prices for insulin vary depending on the region. The company applies 20% reductions from the average prices in western countries as a part of its pricing scheme for the poorest nations (Novo Nordisk, 2009). Moreover, Novo Nordisk deals with World Diabetes Foundation in order to provide funding for the low-income countries (Morsing & Oswald, 2005).

Type of assignment Writer level Title of your paper Pages
Spacing Urgency Currency Total price


Novo Nordisk’s products are distributed from Danish and six other production facilities to other countries mostly by trucks and ships, but also aircrafts. The company works with private wholesalers in different countries, as well as offering insulin on governmental tenders. However, wide wholesaling network sometimes leads to not using Novo Nordisk’s pricing policy since the company cannot guarantee the final price set by wholesalers. It is explained with certain autonomy of local wholesales (Novo Nordisk, 2009).


Insulin production is a specific sphere, which requires ten or more years for developing a product. Therefore, marketing and sales have a responsible task to ensure the realization of investments in R&D. The company has a global marketing approach. Hence, marketing strategies are different for various locations. The company has regional sales and marketing teams in a number of countries. It allows Novo Nordisk to cope with products local adaptations and to develop local marketing strategies (Novo Nordisk, 2012).

Corporate Marketing system at Novo Nordisk consists of New Product Planning team, the Global Marketing team, and the Victoza® team. They are responsible for enlightening customers about the company and its products by using various advertising methods like meetings and events organization, advertisements, direct marketing, online marketing, strategic partnerships, networking, and public relations (Novo Nordisk, 2012).

Novo Nordisk’s customers are diabetics, national governments, and health care providers. However, the peculiarities of insulin market explain Novo Nordisk’s advertisement orientation on healthcare professionals, who prescribe medicine. Thus, the company educates professionals about its insulins, demonstrates production facilities, holds international endocrinology conferences, and provides promotional materials (Novo Nordisk, 2012).

Competitive Comparison

Insulin production is a segment with tough competition. The main competitors of Novo Nordisk are American company Eli Lilly and French pharmaceutical company Sanofi Aventis. All three companies work in the segment of `high quality-high price`. Multiple researchers state that Novo Nordisk is a world leader in insulin market by the innovativeness and quality of products. Pricing policy of Novo Nordisk is better developed than at Eli Lilly and Sanofi Aventis. Novo Nordisk offers lower prices for similar products than its rivals. Additionally, Eli Lilly and Sanofi Aventis do not apply differential pricing policies (Schwartzkopff, 2005).

Novo Nordisk’s distribution system includes 179 sales centers abroad. Eli Lilly and Sanofi Aventis have 143 (Eli Lilly, 2012) and 100 sales offices (Sanofi Aventis, 2009) respectively. It states higher efficiency of Novo Nordisk’s distribution system. Promotion of Novo Nordisk and insulin quality made it a leading company in the sector (Schwartzkopff, 2005).


Therefore, marketing mix of Novo Nordisk can be described as a well developed, efficient, and sustainable system. Novo Nordisk overtakes its competitors by products characteristics, level or prices, broadness of distribution channels, and efficiency of promotion.

Buy Custom Danish Insulin Producer Novo Nordisk Essay

Related essays

  1. Obstacles for Studying Abroad
  2. Transnational Corporation Novo Nordisk
  3. Factors in the Macro Environment
  4. How to Multiply Decimals